The OHSU Knight Cancer Institute gives you the most advanced care possible for blood cancers and other blood disorders. Dr. Brian Druker, the institute’s director, is an internationally renowned expert in blood cancers and targeted cancer medicine. He leads a team of providers who deliver care on the front lines of discovery.
We offer you:
- Lifesaving treatments such as Gleevec, a daily pill for a type of leukemia developed through Dr. Druker’s groundbreaking research.
- The latest immunotherapies for types of leukemia and lymphoma.
- Specialists with deep knowledge of blood cancers and disorders, including rare conditions.
- Team-based care with experts who combine their knowledge for each patient.
- Oregon’s most advanced bone marrow and stem cell transplant center.
- A global center for cancer research, with hundreds of clinical trials to test promising new therapies.
Pioneering innovations: Dr. Druker, through his work on Gleevec, launched the field of precision cancer medicine. He showed that cancer can be targeted at the molecular level, sparing healthy cells. OHSU researchers also helped develop CAR T-cell therapy. This innovative immunotherapy modifies a patient’s own blood cells to fight types of leukemia and lymphoma.
National recognition: The Knight Cancer Institute earned the National Cancer Institute’s highest research designation.
Leadership: Dr. Druker and OHSU’s Jeff Tyner, Ph.D., have joined the Leukemia and Lymphoma Society in Beat AML. This national effort, in cooperation with universities across the U.S., aims to develop new treatments for acute myeloid leukemia.
Advanced training: All our doctors completed fellowships, adding at least a year of hands-on training in blood disorders, cancer and other related specialties. Nurses in our stem cell transplant and intensive care units are specially trained to meet your needs.
A team focused on your needs: Our specialists meet frequently to go over treatment options patient by patient. You benefit from the full team’s expertise. We consider every option, including clinical trials, when developing your treatment recommendations.
Experts in your specific illness: Our doctors work in groups that focus on subtypes of leukemia, lymphoma and other blood disorders. You benefit from their unmatched knowledge of the treatments likely to work best for your specific condition.
Convenience: Our nurse coordinators arrange your appointments and answer questions so you can focus on your care. We also offer services at our central Portland campuses, at Portland-area community clinics, and in central and southern Oregon.
Clinical trials and research
Clinical trials: The Knight Cancer Institute leads hundreds of clinical trials to test better ways to prevent, detect, diagnose and treat cancer. Your care team will discuss whether one of these studies is right for you.
Research: We are bringing together the world’s best minds in cancer research to our state-of-the-art Knight Cancer Research Building. It includes our Cancer Early Detection Advanced Research Center, which is dedicated to finding cancer when it’s most curable.
Call 503-494-7999 to:
- Request an appointment
- Seek a second opinion
- Ask questions
Refer a patient
- Refer your patient to OHSU.
- Call 503-494-4567 to seek provider-to-provider advice.
Meet Muiread Pickett, one of the dedicated OHSU scientists who does testing for leukemia and lymphoma patients.